Cancer Institute of NJ, UW Carbone Reap $4.3M for Genomic Medicine Trial | GenomeWeb

NEW YORK (GenomeWeb News) – Investigators at the
Rutgers Cancer Institute of New Jersey (CINJ) and the University of Wisconsin Carbone Cancer Center have won a $4.3 million grant from the National Cancer Institute to conduct a clinical trial seeking to identify and use genomic biomarkers to provide targeted cancer treatments, CINJ said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.